All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @thesknmedic5 on TikTok · 60s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @thesknmedic5's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00You've got the words to change

@thesknmedic5's peptide reconstitution video, fact-checked

THESKNMEDIC

TikTok creator

7.2K viewsWatch on TikTok

Quick answer

GHK-Cu and SS-31 are investigational peptides with limited clinical data. SS-31 failed its primary endpoint in a phase 3 trial for mitochondrial disease, while GHK-Cu has only small cosmetic studies. Neither is FDA-approved for therapeutic use.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @thesknmedic5's peptide reconstitution video, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@thesknmedic5's peptide reconstitution video, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@thesknmedic5's peptide reconstitution video, fact-checked" from THESKNMEDIC. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GHK-Cu and SS-31 are investigational peptides with limited clinical data.

The reason this review is not generic is the source wording and the canonical claim label "peptides provenpeptides for research purposes only not for human." In this clip, the useful excerpt is: "You've got the words to change" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

GHK-Cu studies are limited to small cosmetic trials, including a 20-person industry-funded study from 2012
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GHK-Cu and SS-31 are investigational peptides with limited clinical data.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GHK-Cu and SS-31 are investigational peptides with limited clinical data. SS-31 failed its primary endpoint in a phase 3 trial for mitochondrial disease, while GHK-Cu has only small cosmetic studies. Neither is FDA-approved for therapeutic use.
  • SS-31 failed its primary endpoint in the MMPOWER-3 phase 3 trial for primary mitochondrial myopathy in 2020
  • GHK-Cu studies are limited to small cosmetic trials, including a 20-person industry-funded study from 2012

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • SS-31 failed its primary endpoint in the MMPOWER-3 phase 3 trial for primary mitochondrial myopathy in 2020
  • GHK-Cu studies are limited to small cosmetic trials, including a 20-person industry-funded study from 2012
  • A 2021 analysis found 11 of 14 peptide products contained different amounts than labeled, with some having no active ingredient
  • "Research purposes only" disclaimers don't protect consumers from contaminated or mislabeled products
  • The FDA issued warning letters to peptide suppliers in 2019 for marketing unapproved drugs
  • Legitimate peptide therapy requires medical supervision and pharmaceutical-grade compounds from licensed facilities
  • DIY peptide reconstitution introduces contamination risks that most people can't properly manage at home

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

The TikTok shows someone reconstituting peptides, specifically mentioning GHK-Cu and SS-31, with a disclaimer stating "for research purposes only, not for human consumption." The creator uses hashtags suggesting this is educational content about peptide preparation.

The video doesn't make explicit health claims but implies these peptides have therapeutic value. The "research purposes only" disclaimer is likely meant to skirt FDA regulations, since these compounds aren't approved for human use outside clinical trials.

By showing reconstitution techniques, the creator is essentially providing a how-to guide for preparing these research chemicals, despite the legal disclaimers.

Are GHK-Cu and SS-31 actually promising compounds?

GHK-Cu has shown wound healing properties in small studies, but the evidence is limited. A 2012 study by Pickart et al. found improved skin appearance in 20 women after 12 weeks, but this was industry-funded research with a tiny sample size.

SS-31 (elamipretide) is more legitimate. Stealth BioTherapeutics has conducted actual clinical trials for mitochondrial disorders. Their phase 3 MMPOWER-3 trial for primary mitochondrial myopathy failed to meet endpoints in 2020, though the company continues development.

The problem isn't that these compounds are useless. It's that buying them from peptide suppliers online gives you no guarantee of purity, sterility, or dosing accuracy.

What's wrong with the "research only" disclaimer?

This disclaimer is legal theater. Companies selling these peptides know exactly who's buying them and why. The "research purposes only" label doesn't make these compounds safer or more legal for human use.

The FDA has repeatedly warned companies about selling unapproved peptides. In 2019, they issued warning letters to multiple peptide suppliers for marketing drugs without approval. These disclaimers don't protect consumers from contaminated or mislabeled products.

Real research institutions don't buy peptides from Instagram-advertised suppliers. They source from established chemical companies with proper documentation and quality control.

Why is DIY peptide use risky?

Reconstituting peptides at home introduces multiple contamination risks. These compounds require sterile technique, proper storage, and accurate dosing that most people can't achieve in their kitchens.

A 2021 analysis by Supplement Safety Solutions found that 11 of 14 peptide products contained different amounts than labeled. Some had no active ingredient at all. Others contained bacterial endotoxins that could cause serious infections.

Without proper testing, users have no idea what they're injecting. The peptide space is largely unregulated, with suppliers making products in facilities that may not meet basic safety standards.

What should you know about peptide therapy?

Legitimate peptide therapy exists through compounding pharmacies and medical supervision. Some peptides like semaglutide and tesamorelin are FDA-approved for specific conditions.

If you're interested in peptide therapy, work with a doctor who can prescribe pharmaceutical-grade compounds. They can monitor for side effects and ensure proper dosing based on your individual needs.

The "research peptide" market exploits regulatory loopholes while putting consumers at risk. Real therapeutic benefits require real medical oversight, not TikTok tutorials and legal disclaimers.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

THESKNMEDIC · TikTok creator

7.2K views on this video

@ProvenPeptides For research purposes only Not for human consumption Peptide Professional Reconstitute with me #peptide #ghk #mitochondria #ss31 #reconstitution

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ss-31 failed its primary endpoint in the mmpower-3 phase 3?

SS-31 failed its primary endpoint in the MMPOWER-3 phase 3 trial for primary mitochondrial myopathy in 2020

What does the video say about ghk-cu studies?

GHK-Cu studies are limited to small cosmetic trials, including a 20-person industry-funded study from 2012

What does the video say about a 2021 analysis found 11 of 14 peptide products contained?

A 2021 analysis found 11 of 14 peptide products contained different amounts than labeled, with some having no active ingredient

What does the video say about "research purposes only" disclaimers don't protect consumers from contaminated?

"Research purposes only" disclaimers don't protect consumers from contaminated or mislabeled products

What does the video say about the fda?

The FDA issued warning letters to peptide suppliers in 2019 for marketing unapproved drugs

What does the video say about legitimate peptide therapy requires medical supervision?

Legitimate peptide therapy requires medical supervision and pharmaceutical-grade compounds from licensed facilities

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by THESKNMEDIC, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.